{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:14:20Z","timestamp":1790187260195,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173422"],"award-info":[{"award-number":["81173422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81130066"],"award-info":[{"award-number":["81130066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Science and Technology Cooperation Program of China","award":["2011DFA31860"],"award-info":[{"award-number":["2011DFA31860"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jep.2015.02.019","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:48:06Z","timestamp":1424134086000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy"],"prefix":"10.1016","volume":"166","author":[{"given":"Tie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionglin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2015.02.019_bib1","first-page":"531","article-title":"Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker","volume":"26","author":"Abe","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jep.2015.02.019_bib2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/pr800643w","article-title":"Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers","volume":"8","author":"Bao","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jep.2015.02.019_bib3","doi-asserted-by":"crossref","first-page":"e2937","DOI":"10.1371\/journal.pone.0002937","article-title":"Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis","volume":"3","author":"Cohen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2015.02.019_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2000.07702.x","article-title":"Aldose reductase and the role of the polyol pathway in diabetic nephropathy","volume":"58","author":"Dunlop","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jep.2015.02.019_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.febslet.2004.12.094","article-title":"Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels","volume":"579","author":"Geoffroy","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jep.2015.02.019_bib500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.aca.2011.01.034","article-title":"Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography\u2013mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy","volume":"689","author":"Han","year":"2011","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jep.2015.02.019_bib501","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jep.2015.02.019_bib6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI118226","article-title":"Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype","volume":"96","author":"Heilig","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jep.2015.02.019_bib7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/diab.46.6.1030","article-title":"D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy","volume":"46","author":"Heilig","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jep.2015.02.019_bib8","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","article-title":"Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by toll-like receptor 4 in mice","volume":"55","author":"Kuwabara","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jep.2015.02.019_bib9","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0024-3205(03)00090-0","article-title":"Decreases of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats","volume":"72","author":"Kwak","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2015.02.019_bib10","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pone.0000097","article-title":"A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle","volume":"1","author":"Laaksonen","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2015.02.019_bib11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1139\/y84-213","article-title":"The lipid content of the diabetic kidney of the rat","volume":"62","author":"Lemieux","year":"1984","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jep.2015.02.019_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/pr060513q","article-title":"Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats","volume":"6","author":"Li","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jep.2015.02.019_bib13","first-page":"129","article-title":"Professor Zhensheng Shi\u05f3 clinical experience in treating chronic nephritis","volume":"6","author":"Li","year":"2005","journal-title":"Zhongguo Zhong xi yi jie he shen bing za zhi=Chin. J. Integr. Tradit. West. Nephrol."},{"key":"10.1016\/j.jep.2015.02.019_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1440-1797.2007.00828.x","article-title":"Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins","volume":"12","author":"Li","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.jep.2015.02.019_bib15","doi-asserted-by":"crossref","first-page":"F205","DOI":"10.1152\/ajprenal.00237.2004","article-title":"Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy","volume":"290","author":"Linden","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jep.2015.02.019_bib16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfq633","article-title":"Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin","volume":"26","author":"Liu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jep.2015.02.019_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s13410-011-0047-x","article-title":"Diabetic nephropathy and associated risk factors for renal deterioration","volume":"32","author":"Mohan","year":"2012","journal-title":"Int. J. Diabetes Dev. Ctry."},{"key":"10.1016\/j.jep.2015.02.019_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1523-1755.2000.07703.x","article-title":"Role of the hexosamine biosynthetic pathway in diabetic nephropathy","volume":"58","author":"Schleicher","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jep.2015.02.019_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","article-title":"Obesity and hyperlipidemia are risk factors for early diabetic neuropathy","volume":"27","author":"Smith","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.jep.2015.02.019_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2013.02.120","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy","volume":"433","author":"Sun","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2015.02.019_bib21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/jpet.303.2.880","article-title":"Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat","volume":"303","author":"Tsutsumi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jep.2015.02.019_bib22","first-page":"1739","article-title":"Effects of Chailing-Yishen formula on rats with chronic nephropathy induced by puromycin aminonucleoside","volume":"15","author":"Wang","year":"2006","journal-title":"Zhongguo Xin yao za zhi=Chin. J. New Drugs"},{"key":"10.1016\/j.jep.2015.02.019_bib23","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jep.2015.02.019_bib24","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1373\/clinchem.2007.089011","article-title":"Metabolomics identifies perturbations in human disorders of propionate metabolism","volume":"53","author":"Wikoff","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jep.2015.02.019_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clinbiochem.2008.10.009","article-title":"Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients","volume":"42","author":"Xia","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jep.2015.02.019_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/726723","article-title":"Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus","volume":"2011","author":"Xie","year":"2011","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.jep.2015.02.019_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jep.2012.07.034","article-title":"Chinese herbal medicine in treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis","volume":"143","author":"Xu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2015.02.019_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jep.2013.11.020","article-title":"Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics","volume":"151","author":"Zhang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2015.02.019_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aca.2009.02.027","article-title":"Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC\u2013oaTOF-MS system","volume":"650","author":"Zhang","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jep.2015.02.019_bib30","first-page":"155","article-title":"Lipidomic Study of Protective Effect of Chaihuang Yishen Graunules on Rats with Diabetic Nephropathy","volume":"18","author":"Zhao","year":"2012","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.jep.2015.02.019_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpba.2011.11.010","article-title":"Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease","volume":"60","author":"Zhao","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jep.2015.02.019_bib32","doi-asserted-by":"crossref","first-page":"e90807","DOI":"10.1371\/journal.pone.0090807","article-title":"Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-\u03b2\/Smad3 signaling","volume":"9","author":"Zhao","year":"2014","journal-title":"PloS one"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874115000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874115000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T06:24:38Z","timestamp":1747635878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874115000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":34,"alternative-id":["S0378874115000975"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2015.02.019","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2015.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}